80030019: What's New In Diabetic Retinopathy and Venous Occlusive Disease

Accreditation Statement The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Statement The Johns Hopkins University School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DESCRIPTION

The total number of people worldwide with diabetes mellitus is projected to rise from 171 million in 2000 to 366 million in 2030. In the United States, almost 24 million or 8 percent of the population has diabetes mellitus. Approximately 4.0 million Americans age 40 and older have diabetic retinopathy, 900,000 of whom have vision threatening disease, defined as severe non-proliferative or proliferative diabetic retinopathy, macular edema, or both. Diabetic retinopathy remains the leading cause of blindness in adults who make up the work force. Despite this, diabetic retinopathy and venous occlusive disease are often under-diagnosed and under-treated. This annual course highlights new information being reported by the Diabetic Retinopathy Clinical Research Network and others, which will impact current standard care and management strategies.

OBJECTIVES

After attending this activity, the participant will demonstrate the ability to:

• Summarize evidence of relation of diabetic control to incidence and severity of retinopathy.
• Diagnose diabetic macular edema, severe non-proliferative retinopathy, and high risk proliferative diabetic retinopathy.
• Determine how best to manage diabetic macular edema, severe non-proliferative diabetic retinopathy, and high risk proliferative diabetic retinopathy
• Recognize new experimental treatment options

Talks

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.